Influenza

DRI plans to demonstrate the capacity to manufacture adjuvant at large scale

IDRI receives $4m from BARDA to create adjuvant manufacturing hub

By Zachary Brennan

Seattle-based Infectious Disease Research Institute (IDRI) has received $4m in funding from the US Biomedical Advanced Research and Development Authority (BARDA) to develop an adjuvant manufacturing hub with both preclinical and clinical expertise to...